Ensuring Clarity and Understandability of the FDA’s Breast Density Notifications

Ensuring Clarity and Understandability of the FDA’s Breast Density Notifications

This Viewpoint discusses the use of breast density notifications to inform women with dense breast tissue of the potential need for supplemental cancer screening, as well as the need to ensure that such notifications are clear and understandable to women of all language backgrounds, literacy levels,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA : the journal of the American Medical Association 2023-01, Vol.329 (2), p.121-122
Hauptverfasser: Kressin, Nancy R, Slanetz, Priscilla J, Gunn, Christine M
Format: Artikel
Sprache:eng
Schlagworte:
Breast - diagnostic imaging
Breast Density
Breast Neoplasms - diagnostic imaging
Early Detection of Cancer
Mammography - standards
United States
United States Food and Drug Administration - legislation & jurisprudence
United States Food and Drug Administration - standards
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This Viewpoint discusses the use of breast density notifications to inform women with dense breast tissue of the potential need for supplemental cancer screening, as well as the need to ensure that such notifications are clear and understandable to women of all language backgrounds, literacy levels, educational levels, and socioeconomic backgrounds.
ISSN:0098-7484
1538-3598
DOI:10.1001/jama.2022.22753